Department of Chemistry
Chevron Science Center
219 Parkman Avenue
Pittsburgh, PA 15260
Developing new reaction technology for the rapid and efficient construction of therapeutically relevant compounds forms the cornerstone of our research program. Reaction development efforts focus primarily on devising metal-based catalytic protocols for executing stereoselective bond constructions. Our principle objective is the rapid and economical preparation of optically active small-molecule building blocks that relate directly to the complex stereochemical and structural motifs embedded in natural product target molecules.
Bristol-Myers Squibb Foundation, Award for Synthetic Chemistry (2001); Eli Lilly & Co., Award for Synthetic Organic Chemistry (2002); Chancellorís Distinguished Research Award (2002)